Fda Milestone Contingent Value Rights Agreement Sample Contracts

FDA MILESTONE CONTINGENT VALUE RIGHTS AGREEMENT

Fda Milestone Contingent Value Rights Agreement • January 19th, 2021 • NantKwest, Inc. • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Fda Milestone Contingent Value Rights Agreement
• Filed
  January 19th, 2021
• Company
  NantKwest, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

THIS FDA MILESTONE CONTINGENT VALUE RIGHTS AGREEMENT, dated as of July 31, 2017 (this “Agreement”), is entered into by and between NANTCELL, INC., a Delaware corporation (“Parent”), and SHAREHOLDER REPRESENTATIVE SERVICES LLC, a Colorado limited liability company, solely in its capacity as the representative of the Unaffiliated Holders (“Stockholder Representative,” and together with Parent, the “Parties”).